Propath Logo

News

Propath hosts nCounter webinar on unlocking FFPE potential in clinical development

Propath hosted a webinar on unlocking the potential of FFPE samples in clinical development using Bruker nCounter technology.

Formalin-fixed, paraffin-embedded (FFPE) tissues represent a valuable resource in clinical and translational research, but can present challenges for molecular analysis. The webinar explored strategies for robust gene expression profiling from FFPE material, highlighting the reliability and reproducibility of nCounter-based workflows and the orthogonal analyses unlocked by enabling FFPE tissue, including a biopharma case study.

Click here to learn more about Propath's services for bulk gene expression in FFPE samples. 

Click here to see a recording of the webinar.

Outsourced R&D - Done better.

At Propath we approach biopharma R&D differently. Say goodbye to Large CRO frustrations –and hello to a more responsive, agile and efficient level of service.